About us

Founded in 2024, with a current fund size of 66M USD, we are a prominent life sciences venture capital working closely with industry innovators to create cutting-edge medications and technologies. Our primary focus is on developing inventive therapeutics that meet unfulfilled medical needs.

Our mission

We adopt a proactive stance in identifying teams focused on developing impactful treatments, aiding in crafting efficient development strategies to make these therapies accessible to patients. Moreover, functioning as an open-ended fund, we extend financial support and networking opportunities to enable young biotech scientists to establish and expand their ventures. By assisting companies in accessing the capital market, our objective is to cultivate a mutually beneficial ecosystem that fosters investment growth, nurtures entrepreneurial successes, and propels the progress of innovative therapeutics.

Portfolio

Contact Us

If you have any questions or inquiries, Please contact us.

Email：ir@beileybiofund.com